128 related articles for article (PubMed ID: 6432359)
1. Hypotension produced by platelet-activating factor is reversed by thyrotropin-releasing hormone.
Feuerstein G; Lux WE; Snyder F; Ezra D; Faden AI
Circ Shock; 1984; 13(3):255-60. PubMed ID: 6432359
[TBL] [Abstract][Full Text] [Related]
2. Thyrotropin-releasing hormone blocks the hypotensive effects of platelet-activating factor in the unanesthetized guinea pig.
Feuerstein G; Lux WE; Ezra D; Hayes EC; Snyder F; Faden AI
J Cardiovasc Pharmacol; 1985; 7(2):335-40. PubMed ID: 2581089
[TBL] [Abstract][Full Text] [Related]
3. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
Toth PD; Mikulaschek AW
Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
[TBL] [Abstract][Full Text] [Related]
4. Thyrotropin-releasing hormone (TRH) and circulatory shock.
McIntosh TK; Faden AI
Circ Shock; 1986; 18(3):241-58. PubMed ID: 3084122
[TBL] [Abstract][Full Text] [Related]
5. Alteration of leukotriene D4 hypotension by thyrotropin releasing hormone.
Lux WE; Feuerstein G; Faden AI
Nature; 1983 Apr; 302(5911):822-4. PubMed ID: 6405279
[TBL] [Abstract][Full Text] [Related]
6. Effect of thyrotropin-releasing hormone on lipoxygenase-induced hypotension in the unanesthetized Guinea pig.
Lux WE; Feuerstein G; Faden AI
Pharm Res; 1984 May; 1(3):135-7. PubMed ID: 24277251
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin-releasing hormone reverses the hypotension and bradycardia produced by leukotriene D4 in unanesthetized guinea pigs.
Lux WE; Feuerstein G; Faden AI
Prostaglandins Leukot Med; 1983 Mar; 10(3):301-7. PubMed ID: 6405395
[TBL] [Abstract][Full Text] [Related]
8. Reversal of leukotriene D4 hypotension by thyrotropin-releasing hormone.
Feuerstein G; Lux WE; Ezra D; Faden AI
Neurosci Res; 1984 Dec; 2(1-2):121-4. PubMed ID: 6443153
[TBL] [Abstract][Full Text] [Related]
9. Thyrotropin releasing hormone: effects in monkeys and dogs subjected to experimental circulatory shock.
Gurll NJ; Holaday JW; Reynolds DG; Ganes E
Crit Care Med; 1987 Jun; 15(6):574-81. PubMed ID: 3105962
[TBL] [Abstract][Full Text] [Related]
10. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor and shock.
Feuerstein G; Siren AL
Prog Biochem Pharmacol; 1988; 22():181-90. PubMed ID: 3043432
[TBL] [Abstract][Full Text] [Related]
12. Role of adrenal steroids in the recovery from platelet activating factor challenge.
Myers AK; Bader TJ
Circ Shock; 1987; 23(2):143-50. PubMed ID: 3677334
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic neuronal systems modulate the central cardiovascular effects of TRH in rats.
Jedrusiak J; Brus R; Kostrzewa RM; Słowiński Z
Pol J Pharmacol; 1995; 47(1):43-52. PubMed ID: 7550548
[TBL] [Abstract][Full Text] [Related]
14. Naloxone and TRH in the treatment of shock and trauma: what future roles?
Bernton EW
Ann Emerg Med; 1985 Aug; 14(8):729-35. PubMed ID: 3927793
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
[TBL] [Abstract][Full Text] [Related]
16. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog.
Rajput SK; Krishnamoorthy S; Pawar C; Kaur N; Monga V; Meena CL; Jain R; Sharma SS
Epilepsy Behav; 2009 Jan; 14(1):48-53. PubMed ID: 18952198
[TBL] [Abstract][Full Text] [Related]
17. Effect of the platelet activating factor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride on endotoxin-induced hypotension and hematological parameters in rats.
Natsume Y; Imanishi N; Koike H; Morooka S
Arzneimittelforschung; 1994 Nov; 44(11):1208-13. PubMed ID: 7848333
[TBL] [Abstract][Full Text] [Related]
18. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
[TBL] [Abstract][Full Text] [Related]
19. PAF, rather than histamine, participates in mouse anaphylactic hypotension.
Shibamoto T; Liu W; Cui S; Zhang W; Takano H; Kurata Y
Pharmacology; 2008; 82(2):114-20. PubMed ID: 18583921
[TBL] [Abstract][Full Text] [Related]
20. Bisxanthones from Hypericum japonicum: inhibitors of PAF-induced hypotension.
Ishiguro K; Nagata S; Oku H; Yamaki M
Planta Med; 2002 Mar; 68(3):258-61. PubMed ID: 11914965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
